Study demonstrates better outcomes with stereotactic radiosurgery compared with whole-brain radiation therapy in postsurgical metastatic brain tumors.
Researchers have discovered a novel biomarker that may predict poor prognosis in African-American triple-negative breast cancer patients.
A new study demonstrates that enhancing the circadian clock function of cancer cells, leads to a reduced rate of growth of tumors.
In this article from Nanomedicine, the potency of trifunctional nanoparticles that target and activate CD8+ dendritic cells is explored.
In this from editorial Melanoma Management the authors explore the use of vaccines in combination with dasatinib for the treatment of stage IIIB–IV melanoma.
Could dendritic cell vaccines be a promising therapeutic strategy for advanced melanoma? Read more in this article from Melanoma Management.